Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,284.00
Bid: 2,287.00
Ask: 2,288.00
Change: 43.00 (1.92%)
Spread: 1.00 (0.044%)
Open: 2,247.00
High: 2,292.00
Low: 2,242.00
Prev. Close: 2,241.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Feb 2011 07:00

RNS Number : 3714B
Halma PLC
17 February 2011
 



 

 

Halma p.l.c.

 

Interim Management Statement

 

17 February 2011

 

 

Halma, the leading safety, health and sensor technology group today makes an Interim Management Statement prior to its financial year end on 2 April 2011, covering the period from 3 October 2010 to date.

 

Based on current trading and forecasts, the Board expects profit (before amortisation of acquired intangibles) for the full year to be in line with current market expectations (see note 2).

 

Revenue in the first six months of the year was 12% ahead of 2009/10 and this trend has continued into the first four months of the second-half year. We have maintained strong returns and good cash generation.

 

The relative performance of each of our sectors and geographic regions has maintained the pattern of the first half with Infrastructure Sensors achieving solid results, Health and Analysis growing strongly and Industrial Safety continuing to deliver improved profitability. All geographic regions are delivering growth and, as expected, we are seeing the strongest growth in emerging economies, reflecting both the increased opportunity in these markets and our ongoing investment.

 

In November 2010, we announced the purchase of Alicat Scientific Inc. (Arizona, USA) and in December 2010, the purchase of Accudynamics Inc. (Massachusetts, USA). Both businesses are trading in line with our expectations as part of our Fluid Technology businesses within the Health and Analysis sector. These acquisitions demonstrate Halma's ability to identify and buy high quality businesses in our selected markets. We are continuing to search for such opportunities in all three sectors.

 

There have been no material events or transactions impacting the Group's financial position which remains robust and provides us with adequate resources for further acquisitions.

 

The results for the financial year ending 2 April 2011 are expected to be released on 21 June 2011.

 

 

For further information, please contact:

 

Halma p.l.c. Tel: +44 (0)1494 721111

Andrew Williams, Group Chief Executive

Kevin Thompson, Group Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

The Board believes current market forecasts to be in the range of £100m to £106.4m with a consensus of £102.7m (2009/10 profit before amortisation of acquired intangibles: £86.2m).

 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMGMZNVKGMZM
Date   Source Headline
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.